alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1 - President Certification (Section 906)

                        CERTIFICATION PURSUANT TO
                         18 U.S.C. SECTION 1350,
                         AS ADOPTED PURSUANT TO
             SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I am the Chief Executive Officer and Chief Financial Officer of Northern
Empire Energy Corp., a Nevada corporation (the "Company").  I am delivering
this certificate in connection with the Form 10-Q of the Company for the
quarter ended September 30, 2009 and filed with the U. S. Securities and
Exchange Commission ("Form 10-Q").

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge,
the Form 10-Q fully complies with the requirements of Section 13(a) or
Section 15(d) of the Securities Exchange Act of 1934 and that the information
contained in the Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of the Company.


/s/ Jeffrey Cocks
-----------------
    Jeffrey Cocks
    President/CFO


Date  November 23, 2009
      -----------------


<PAGE>
#### COMMISSIONER OF INTERNAL REVENUE, Petitioner, v. Louis A. FERGUSON, Respondent.

No. 6067.

Circuit Court of Appeals, Seventh Circuit.

Feb. 15, 1938.

James W. Morris, Department of Justice, of Washington, D. G, for petitioner.

John E. Wing, of Chicago, Ill., for respondent.

Before EVANS and SPARKS, Circuit Judges.

PER CURIAM.

On motion of counsel for petitioner, counsel for respondent consenting thereto, it is now here ordered and adjudged by this court that the petition of the Commissioner of Internal Revenue for a review of the decision, entered on May 14, 1936, in the United States Board of Tax Appeals, be, and the same is hereby, dismissed.
EXHIBIT 32.1
                                                                    ------------


 STATEMENT FURNISHED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002,
                             18 U.S.C. SECTION 1350


The undersigned, Clement B. Knapp, Jr., is the President and Chief Executive
Officer of AMB Financial Corp. (the "Company").

This statement is being furnished in connection with the filing by the Company
of the Company's Annual Report on Form 10-K for the year ended December 31, 2003
(the "Report").

By execution of this statement, I certify that:

     1.   the Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or
          78o(d)) and

     2.   the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company as of the dates and for the periods covered by the
          Report.

     This statement is authorized to be attached as an exhibit to the Report so
that this statement will accompany the Report at such time as the Report is
filed with the Securities and Exchange Commission pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350. It is not intended that this
statement be deemed to be filed for purposes of the Securities Exchange Act of
1934, as amended.



March 24, 2004                                     /s/ Clement B. Knapp, Jr.
--------------                                     -----------------------------
Dated                                              Clement B. Knapp, Jr.
**Exhibit
      23**




**Consent
      of Cobitz, VandenBerg & Fennessy**


**Cobitz,
      VandenBerg & Fennessy**


**CERTIFIED
      PUBLIC ACCOUNTANTS**


**9944
      S. Roberts Road • Suite 202**


**Palos
      Hills, Illinois 60465**


**―**


**(708)
      430-4106 • FAX (708) 430-4499**




**INDEPENDENT
      AUDITOR’S CONSENT**




We
      hereby
      consent to the incorporation by reference and use of our report, dated January
      12, 2007 on the consolidated financial statements of AMB Financial Corp. which
      appears in AMB Financial Corp.’s Annual Report of Shareholders and Form 10-KSB
      for the year ended December 31, 2006.




/s/
      Cobitz, VandenBerg & Fennessy





March
      30,
      2007


Palos
      Hills, Illinois
* Pursuant to 5 TH C IR
. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR
. R. 47.5.4. United States Court of Appeals Fifth Circuit 

### FILED August 8, 2007 Charles R. Fulbruge III Clerk 

### IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 06-51633 Conference Calendar
UNITED STATES OF AMERICA Plaintiff-Appellee
v. LUIS ROBERTO ZAMORANO-GRAJEDA Defendant-Appellant Appeal from the United States District Court for the Western District of Texas USDC No. 3:06-CR-1381-ALL Before DENNIS, CLEMENT, and PRADO, Circuit Judges. PER CURIAM: * Appeal ing the Judgment in a Criminal Case, Luis Roberto ZamoranoGrajeda raises arguments that are foreclosed by A lmendarez-Torres v. United States, 523 U.S. 224, 235 (1998), which held that 8 U.S.C. § 1326(b)(2) is a penalty provision and not a separate criminal offense. The Government's motion for summary affirmance is GRANTED, and thejudgment ofthe district court is AFFIRMED.
1

UNITED STATES DISTRICT COURT

EASTERN DISTRICT OF MICHIGAN

SOUTHERN DIVISION

PHILLIP BROWN,

Petitioner,

v. Case No. 09-11679

Honorable Patrick J. Duggan

SHIRLEE HARRY,

Respondent.

____________________________/

ORDER DENYING PETITIONER’S MOTION

FOR RELIEF FROM JUDGMENT

At a session of said Court, held in the U.S.

District Courthouse, Eastern District

of Michigan, on August 30, 2010.

PRESENT: THE HONORABLE PATRICK J. DUGGAN

 U.S. DISTRICT COURT JUDGE

This matter is before the Court on Petitioner’s motion for relief from judgment

pursuant to Federal Rule of Civil Procedure 60(b)(1) and (2), filed August 4, 2010. In his

motion, Petitioner seeks relief from the Court’s July 13, 2009 denial of his motion to hold

his habeas petition in abeyance and the non-prejudicial dismissal of his petition to allow

him to fully exhaust his state court remedies as to his habeas claims. Petitioner contends

that the Court should have held his “mixed petition” in abeyance rather than dismissing it

without prejudice. Petitioner already filed a motion for reconsideration with respect to

the Court’s decision, which the Court denied on August 7, 2009.
2

Under Federal Rule of Civil Procedure 60(b), a district court may grant relief from

a final judgment or order only upon a showing of one of the following reasons:

(1) mistake, inadvertence, surprise, or excusable neglect;

(2) newly discovered evidence that, with reasonable diligence, could not

have been discovered in time to move for a new trial under Rule 59(b);

(3) fraud (whether previously called intrinsic or extrinsic),

misrepresentation, or misconduct by an opposing party;

(4) the judgment is void;

(5) the judgment has been satisfied, released, or discharged; it is based on

an earlier judgment that has been reversed or vacated; or applying it

prospectively is no longer equitable; or

(6) any other reason that justifies relief.

Fed. R. Civ. P. 60(b). A motion under Rule 60(b) must be made within a reasonable time,

but for reasons (1) through (3) no more than one year after the entry of the judgment,

order, or proceeding challenged in the motion.

Petitioner claims in his motion for relief from judgment that the Court made a

mistake in denying his habeas petition, yet he did not file his motion within one year of

the Court’s decision. His motion, therefore, is untimely. The time limit is jurisdictional

and a district court does not have discretion to extend the period of limitation. See

Mitchell v. Rees, 261 F. App’x 825, 830 (6th Cir. 2008) (citing Smith v. Sec’y of Health &

Human Servs., 776 F.2d 1330, 1332-33 (6th Cir. 1985)).

Accordingly,
3

IT IS ORDERED, that Petitioner’s motion for relief from judgment is DENIED.

s/PATRICK J. DUGGAN

UNITED STATES DISTRICT JUDGE

Copy to:

Phillip Brown, 271566

Oaks Correctional Facility

1500 Caberfae Highway

Manistee, Michigan 49660
EXHIBIT 31.1  I, Mislav Pavelic, in my capacity indicated below, certify that:  1. I have reviewed this annual report on Form 10-Q of Opencell Biomed, Inc. (the Registrant); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report; 4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have: a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared; b) evaluated the effectiveness of the Registrants disclosure controls and procedures and presented in this report my conclusion about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and c) disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; 5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of Registrant's board of directors (or persons performing the equivalent function): a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.  Date: July 20, 2009 /s/ Mislav Pavelic Mislav Pavelic, President (as Principal Executive Officer)
[Federal Register Volume 73, Number 155 (Monday, August 11, 2008)]
[Notices]
[Page 46634]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-18274]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases, Special Emphasis Panel, R25 Science Education Awards.
    Date: August 27, 2008.
    Time: 8 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive 
3145, Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Ellen S. Buczko, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institutes of Health/NIAID, 6700B Rockledge Drive, Room 
3145 MSC 7616, Bethesda, MD 20892-7616, 301-451-2676, 
<a href="/cdn-cgi/l/email-protection#9afff8eff9e0f1f5abdaf4f3fbf3feb4f4f3f2b4fdf5ec"><span class="__cf_email__" data-cfemail="f6939483958c9d99c7b6989f979f92d8989f9ed8919980">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases, Special Emphasis Panel, Host Response to Pathogens.
    Date: September 17, 2008.
    Time: 11 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Lynn Rust, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, NIAID/
NIH/DHHS, Room 3120, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 
20892, 301-402-3938, <a href="/cdn-cgi/l/email-protection#cca0befefef4ba8ca2a5a4e2aba3ba"><span class="__cf_email__" data-cfemail="c5a9b7f7f7fdb385abacadeba2aab3">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: July 31, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-18274 Filed 8-8-08; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
FIRST DISTRICT COURT OF APPEAL

STATE OF FLORIDA

_____________________________

No. 1D19-2128

_____________________________

DERRICK WALKER,

Petitioner,

v.

PROGRESSIVE SELECT 

INSURANCE CO.,

Respondent.

_____________________________

Petition for Writ of Prohibition—Original Jurisdiction.

September 11, 2019

PER CURIAM.

The petition for writ of prohibition is denied on the merits.

ROWE, OSTERHAUS, and KELSEY, JJ., concur.

_____________________________

Not final until disposition of any timely and 

authorized motion under Fla. R. App. P. 9.330 or 

9.331.

_____________________________
2

Derrick Walker, pro se, Petitioner.

No appearance for Respondent.
<PAGE>
                                                                    EXHIBIT 23.2




                         CONSENT OF INDEPENDENT AUDITORS

We consent to the incorporation by reference in the Registration Statements
(Forms S-8 No. 33-80147 and 333-52044) pertaining to the 1993 Stock Option Plan,
1994 Director's Stock Option Plan and Directors' Warrants and 2000 Directors'
Stock Option Plan and 2000 Employee Stock Option Plan of SigmaTron
International, Inc. of our report dated June 29, 2001, except for the third
paragraph of note Q, as to which the date is July 11, 2001, with respect to the
consolidated financial statements and schedule of SigmaTron International, Inc.
and our report dated June 29, 2001 with respect to the financial statements and
schedule of SMT Unlimited, L.P. included in the Annual Report (Form 10-K) of
SigmaTron International, Inc. for the year ended April 30, 2002.


                                               /s/ ERNST & YOUNG


Chicago, Illinois
July 22, 2002
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[H.R. 47 Introduced in House (IH)]

104th CONGRESS
  1st Session
                                 H. R. 47

      To require approval by law of agency rules and regulations.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 4, 1995

 Mr. Taylor of North Carolina introduced the following bill; which was 
               referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
      To require approval by law of agency rules and regulations.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Regulatory Relief and Reform Act''.

SEC. 2. AGENCY RULES REQUIRED TO BE APPROVED BY LAW.

    (a) Approval Requirement.--Section 553 of title 5, United States 
Code, is amended--
            (1) in subsection (a), in the matter preceding paragraph 
        (1), by striking ``except to the extent'' and inserting 
        ``except that subsections (b), (c), (d), and (e) do not apply 
        to the extent''; and
            (2) by adding at the end the following:
    ``(f) A rule or regulation shall not be effective unless it is 
approved by law.''.
    (b) Application.--The amendment made by subsection (a) shall apply 
to--
            (1) a rule or regulation issued in final form after the 
        date of the enactment of this Act; and
            (2) a rule or regulation issued in final form before the 
        date of the enactment of this Act, if the first effective date 
        of the rule or regulation occurs after the date of the 
        enactment of this Act.
                                 <all>
```
#### Mary S. LAULO, Appellant, v. Eleanor Koch REHM, Respondent.

No. 71161.

Missouri Court of Appeals, Eastern District, Division One.

Oct. 22, 1996.

Mary S. Laulo, Imperial, pro se.

Michael J. Valenti, HUlsboro, for Respondent.

*863Before DOWD, P.J., and REINHARD and GARY M. GAERTNER, JJ.

ORDER

PER CURIAM.

Mary S. Laulo (Contestant), pro se, appeals the judgment of the trial court dismissing, for lack of subject matter jurisdiction, her challenge to primary election results, § 115.526, RSMo 1994. We affirm. An extended opinion would have no precedential value. The parties have been furnished with a memorandum for their information only, setting forth the reasons for this order affirming the judgment of the trial court. Rule 84.16(b).
Exhibit 32.2






CERTIFICATION PURSUANT TO






18 U.S.C. Section 1350,






AS ADOPTED PURSUANT TO






SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002






In connection with the Quarterly Report of Advanced BioMedical Technologies, Inc. (the "Company") on Form 10-Q for the period ended January 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "report"), I, Kai GUI, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:






(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and






(2)           The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.











Dated this 21st day of March, 2012..









/s/ Kai GUI


Kai GUI, Director, Secretary, and Chief Financial Officer
# United States Court of Appeals For the Eighth Circuit

___________________________

No. 21-2078

___________________________

Mark Bitzan lllllllllllllllllllll Plaintiff - Appellant

v. Jerry Bartruff, Former IDOC Director; John Baldwin, Former IDOC Director; Dorothy Faust, Former IDOC Director; Sheryl Dahm, Former IDOC Director; Jay Nelson, Former IDOC Director; Nick Ludwick, Former IDOC Director

lllllllllllllllllllll Defendants Mark Roberts, ISP Deputy Warden; Rebecca Bowker, ISP Executive Officer; Mike Schierbrock, ISP A/W Treatment; Jill Johnson, ISP Administrative Assistant

lllllllllllllllllllll Defendants - Appellees Debbie Ferril, Former IDOC Director lllllllllllllllllllll

Defendant David DeGrange, ISP Investigator lllllllllllllllllllll Defendant - Appellee Randy VanWye, Former IDOC Director; Nikki Eaves, Former IDOC Director;

Cynthia Phillips, Former IDOC Director lllllllllllllllllllll Defendants Berl Wilcox, ISP Segregation Unit Manager; Mike Eisnnicher, ISP Segregation Committee

lllllllllllllllllllll Defendants - AppelleesBradley Hoenig, Former IDOC Director; Statewide Religion Review Committee; Julie Johnson, ISP Former A/W Administration; Debbie Nichols, ISP Former A/W Security; Jane Doe, ISP Mailroom

lllllllllllllllllllll Defendants

____________ Appeal from United States District Court for the Southern District of Iowa

____________ Submitted: April 19, 2022 Filed: April 25, 2022 [Unpublished]

____________ Before LOKEN, KELLY, and GRASZ, Circuit Judges.

____________ PER CURIAM. Iowa inmate Mark Bitzan appeals the district court’s 1 adverse judgment following a bench trial on his retaliation claims under 42 U.S.C. § 1983. After careful review, we affirm for the reasons stated by the district court. See Muhammad v. Mayfield , 933 F.3d 993, 1000 (8th Cir. 2019) (reviewing factual findings for clear error and legal conclusions de novo for appeal from bench trial). The judgment is affirmed. See 8th Cir. R. 47B.

______________________________

1 The Honorable John A. Jarvey, then Chief Judge, United States District Court for the Southern District of Iowa, now retired, adopting the report and recommendation of the Honorable Helen C. Adams, Chief United States Magistrate Judge for the Southern District of Iowa. -2-
[Federal Register Volume 73, Number 157 (Wednesday, August 13, 2008)]
[Notices]
[Page 47197]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-18509]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Mechanisms of Tissue Destruction in 
Rheumatoid Arthritis.
    Date: September 5, 2008.
    Time: 11 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive Room 
3256, Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Wendy F. Davidson, PhD, Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-402-8399, 
<a href="/cdn-cgi/l/email-protection#92f6f3e4fbf6e1fdfce5d2fff3fbfebcfcfbfabcf5fde4"><span class="__cf_email__" data-cfemail="680c091e010c1b07061f280509010446060100460f071e">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 5, 2008.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-18509 Filed 8-12-08; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>